Minerva Neurosciences, Inc. (NERV)

2.32 +0.08 (+3.57%) USD  |  NASDAQ  |  Oct 30, 16:00
2.30 -0.02 (-0.86%) Pre-Market: 20:00
More

Minerva Neurosciences Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for NERV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
August 14, 2026 --
August 10, 2026 --
August 07, 2026 --
May 11, 2026 --
May 05, 2026 --
April 15, 2026 --
March 12, 2026 --
December 01, 2025 --
November 06, 2025 --
Date Value
November 06, 2024 --
August 07, 2024 --
May 02, 2024 --
February 23, 2024 --
November 10, 2023 --
August 02, 2023 --
May 16, 2023 --
March 09, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Heron Therapeutics, Inc. Upgrade
Tonix Pharmaceuticals Holding Corp. Upgrade
Karyopharm Therapeutics, Inc. Upgrade
Corbus Pharmaceuticals Holdings, Inc. Upgrade
Ocugen, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade